Quarterly report pursuant to Section 13 or 15(d)

REVENUE (Tables)

v3.24.1.1.u2
REVENUE (Tables)
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table represents a disaggregation of revenue for the three months ended March 31, 2024 and 2023:

 

    2024     2023  
    Three Months Ended March 31,  
    2024     2023  
    ($ in thousands)  
Healthcare IT:                
Technology-enabled business solutions   $ 17,283     $ 19,495  
Professional services     4,422       6,560  
Printing and mailing services     861       713  
Group purchasing services     155       186  
Medical Practice Management:                
Medical practice management services     3,241       3,047  
Total   $ 25,962     $ 30,001  
SCHEDULE OF CHANGES IN ACCOUNTS RECEIVABLE, CONTRACT ASSET AND DEFERRED REVENUE

 

    Accounts Receivable - Net     Contract Asset     Deferred Revenue (current)     Deferred Revenue (long term)  
    ($ in thousands)  
Balance as of January 1, 2024   $ 11,888     $ 5,094     $ 1,380     $ 256  
Increase, net     74       361       6       52  
Balance as of March 31, 2024   $ 11,962     $ 5,455     $ 1,386     $ 308  
                                 
Balance as of January 1, 2023   $ 14,773     $ 4,399     $ 1,386     $ 342  
(Decrease) increase, net     (127 )     619       8       8  
Balance as of March 31, 2023   $ 14,646     $ 5,018     $ 1,394     $ 350  

SCHEDULE OF TRADE ALLOWANCE FOR DOUBTFUL ACCOUNTS

Changes in the allowance for expected credit losses for trade accounts receivable are presented in the table below:

 

    Three Months Ended     Year Ended  
    March 31, 2024     December 31, 2023  
    ($ in thousands)  
Beginning balance   $ 879     $ 823  
Adoption of ASC 326     -       186  
Provision     37       454  
Recoveries/adjustments     1       107  
Write-offs     -       (691 )
Ending balance   $ 917     $ 879